fbpx

World Pharma News

05

Aug2016
Controlling human nerve cells with electricity could treat a range of diseases including arthritis, asthma and diabetes, a ... Read More

05

Aug2016
The atrial fibrillation market will expand from approximately $8 billion in 2015 to hit its peak of $11.8 ... Read More

04

Aug2016
Most drug manufacturers respond immediately to the FDA after having their plant operations criticized in an inspection. Not ... Read More

04

Aug2016
Japan’s Astellas has sold its U.S.-based manufacturing operation, Astellas Pharma Technologies, to a U.S. contract manufacturer, which will ... Read More
X
Send a message
Request a call

* Required fields

By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

* Required fields

By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.